CIK 0001799191
- Accelerated filer
- Smaller reporting company
Starling Oncology, Inc.
Sign in to watch- Tickers
- STLN STLNW DFPH
- Exchange
- Nasdaq, OTC
- Industry
- Services-Offices & Clinics of Doctors of Medicine
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 843562323
- Phone
- +1 562-735-3226
- Business address
- 18000 STUDEBAKER RD, SUITE 800, CERRITOS, CA, 90703
- Former names
- Oncology Institute, Inc., DFP HEALTHCARE ACQUISITIONS CORP.
Securities
- STLN Common Stock Nasdaq
- STLNW Common stock Nasdaq
- DFPH Common stock OTC
- 4 Open-market sale 10% owner sold 25,614 shares at an average $4.33 ($110,826)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale 10% owner sold 288,129 shares at an average $4.50 ($1,296,669)
- 4 Open-market sale 10% owner sold 128,285 shares at an average $5.27 ($675,507)
- 4 Open-market sale 10% owner sold 87,400 shares at an average $5.99 ($523,360)
- 4 Open-market sale 10% owner sold 157,483 shares at an average $5.99 ($943,613)
- 4 Open-market sale 10% owner sold 78,500 shares at an average $6.23 ($489,415)
- 4 Open-market sale 10% owner sold 64,609 shares at an average $6.15 ($397,360)
- 4 Open-market sale 10% owner sold 94,473 shares at an average $6.57 ($620,434)
- 4 Open-market sale 10% owner sold 50,000 shares at an average $6.49 ($324,388)
- 4 Derivatives Options or other derivatives
- 4 Grant or award Chief Financial Officer acquired 32,121 shares (grant or award)
- 4 Open-market sale 10% owner sold 1,600,000 shares at $6.00 ($9,600,000)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4/A Derivatives Options or other derivatives
- 4/A Derivatives Options or other derivatives
- 4/A Derivatives Options or other derivatives
- 4/A Derivatives Options or other derivatives
Page 11 of 14 · 270 filings